The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

被引：424
|
作者：
Cookson, Mark R. [1 ]
机构：
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20982 USA
来源：
NATURE REVIEWS NEUROSCIENCE | 2010年 / 11卷 / 12期
基金：
美国国家卫生研究院;
关键词：
AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; CYTOPLASMIC LOCALIZATION; 14-3-3; BINDING; ROC DOMAIN; MUTATIONS; PROTEIN; PHOSPHORYLATION; GENE;
D O I：
10.1038/nrn2935
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene-leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically a-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.
引用
收藏
页码：791 / 797
页数：7
相关论文
共 50 条
  • [1] The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
    Mark R. Cookson
    Nature Reviews Neuroscience, 2010, 11 : 791 - 797
  • [2] Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease
    Domingos, Sofia
    Duarte, Teresa
    Saraiva, Lucilia
    Guedes, Rita C.
    Moreira, Rui
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 1953 - 1977
  • [3] Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond
    Bae, Jae Ryul
    Lee, Byoung Dae
    BMB REPORTS, 2015, 48 (05) : 243 - 248
  • [4] Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
    Lee, Byoung Dae
    Dawson, Valina L.
    Dawson, Ted M.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (07) : 365 - 373
  • [5] Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease
    Bardien, Soraya
    Lesage, Suzanne
    Brice, Alexis
    Carr, Jonathan
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (07) : 501 - 508
  • [6] Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson's Disease
    Gandhi, Payal N.
    Chen, Shu G.
    Wilson-Delfosse, Amy L.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (06) : 1283 - 1295
  • [7] Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson’s disease
    Julie P. Taylor
    Mary M. Hulihan
    Jennifer M. Kachergus
    Heather L. Melrose
    Sarah J. Lincoln
    Kelly M. Hinkle
    Jeremy T. Stone
    Owen A. Ross
    Robert Hauser
    Jan Aasly
    Thomas Gasser
    Haydeh Payami
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2007, 8 : 95 - 102
  • [8] Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson's Disease
    Gilligan, Paul J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (10) : 927 - 938
  • [9] Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson's disease
    Kluss, Jillian H.
    Lewis, Patrick A.
    Greggio, Elisa
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (06) : 537 - 546
  • [10] Leucine-rich repeat kinase 1:: a paralog of LRRK2 and a candidate gene for Parkinson's disease
    Taylor, Julie P.
    Hulihan, Mary M.
    Kachergus, Jennifer M.
    Melrose, Heather L.
    Lincoln, Sarah J.
    Hinkle, Kelly M.
    Stone, Jeremy T.
    Ross, Owen A.
    Hauser, Robert
    Aasly, Jan
    Gasser, Thomas
    Payami, Haydeh
    Wszolek, Zbigniew K.
    Farrer, Matthew J.
    NEUROGENETICS, 2007, 8 (02) : 95 - 102
12345